A Spotlight on Healthcare Communications Advocacy by Alastair Kent
July 24, 2017 | Alastair Kent, Communiqué Awards, Genetic Alliance UK, Healthcare Communications Advocacy, Rare disease UK, Say Communications, patient advocacy, rare disease
Earlier this year I received an email from Stefi Rucci asking me if I would mind if she nominated me for the Healthcare Advocate of the Year at this year’s Communique Awards Ceremony. I was flattered that she should think of me as a potential candidate, and honoured to be nominated but frankly never expected this to go any further. When Stefi invited me to join the Say Communications party at the ceremony I thought it would be a splendid evening in great company but was still not expecting anything more. So I wasn’t really paying attention when the winner’s citation was being read out until mid way through, when I realised that the person being recognised with the award was actually me!
Wow! What an honour to receive this accolade, especially in the light of previous winners, superstars in the healthcare communications firmament all! In an instant I was transformed from (hopefully) a moderately intelligent dinner companion to a gibbering wreck. To say I was thrilled is to understate the case by several orders of magnitude, and I am deeply grateful to Stefi, her colleagues at Say Communications and all those who sent in testimonials supporting the nomination.
But being named Healthcare Advocate of the Year is not just a personal triumph. Until recently I was Director of Genetic Alliance UK, the umbrella body for all those affected by rare and genetic disorders. This is a policy focused health charity which seeks to provide a patient and family perspective on issues relating to biomedical research and healthcare policy, planning and service delivery. Genetic Alliance UK has built up expertise and credibility thanks to the hard work of a motivated and very knowledgeable team which I have had the privilege to lead. In today’s fast moving research environment, where new knowledge brings hope to patients and families, and creates opportunities for improving the services and support that the NHS can provide, articulating the patient and family perspective – speaking truth to power – so those who can influence the future shape of healthcare can hear, understand and act upon is increasingly important. This is especially the case for those with rare diseases. For too long “rare” was seen as synonymous with “not very important”. Today, rare diseases are high up on the agenda for researchers and for the NHS , thanks in part to effective advocacy by patients and families, by the support groups for those with specific conditions and by umbrella bodies such as Genetic Alliance UK. Winning the Healthcare Advocate of the Year is not just a personal accolade, but an acknowledgement of the growing impact that the views of patients and families have rightly assumed in the debate over research priorities and NHS resource allocation at all levels from person to person interactions between an individual and their doctor to engaging with the Secretary of State and the CEOs of multi-national pharma companies.
There are some take home messages from winning this award for me and perhaps for my colleagues engaged in healthcare advocacy in whatever capacity. The first is to be clear what it is you are trying to achieve, and why it matters to those for whom you advocate. Understand the mind set and the constraints those you need to influence are operating under, and try to generate evidence that will support the arguments you need to make to bring about the desired result. Emotion, “skin in the game”, is important, but it is an adjunct to, not a substitute for reasoned argument, and finally, I have never met anyone in the research or healthcare arena who deliberately sets out to do a bad job. Circumstances may prevent them from doing a good one, but it is the job of the healthcare advocate to help them bring this about. Winning this award is vindication for this approach. The glory is not mine alone, but should be seen as recognition for effective advocates everywhere who are committed to improving the lot of those on whose behalf they speak.
Author:
Alastair Kent OBE was the Director of Genetic Alliance UK for over 20 years, and is currently Ambassador for the organisation. Genetic Alliance UK is a national charity of over 180 patient organisations, supporting all those affected by genetic conditions. Genetic Alliance UK’s mission is to promote the development of the scientific understanding of genetics and the part that genetic factors play in health and disease, and to see the speedy transfer of this new knowledge into improved services and support for patients. He is also Chair of Rare Disease UK. Rare Disease UK is a national alliance for people with rare diseases and all who support them. Alastair has worked in the field of genetic and rare disease healthcare for over 20 years. Alastair represents the interests of patients on numerous platforms.
Alastair’s guest blog fro Say Communications can be found here: http://www.saycomms.co.uk/blog/2017/07/communications-advocacy/
This content was provided by Say Communications
Company Details
Latest Content from Say Communications
The 7 truths behind successful Healthcare influencer engagement programmes
Pharma companies need to be engaging DOLs in the same way as Key Opinion Leaders (KOLs). But how can companies ensure best practice DOL engagement? Here are Say’s recommended critical...
Say wins Communiqué Awards for corporate influencer campaign based on life hacks
SAY received the top recognition for the ‘Excellence in Corporate Communications’ and ‘Excellence in Engagement Through Social Media/Digital Channels – Under £50,000’ categories with our “Lift Up Your Everyday with...
The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment
Advances in cancer treatment are frequent, but how much do we actually understand about these new treatments?
Meeting the experts behind the story: How building a bicycle led to a revolution in respiratory health
Hear from Professor Wladyslaw Wygnanski, inventor of a revolutionary respiratory medical device called BiMOD.
How ‘Greenwashing’ accusations could delay the very changes its supporters demand
Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...
The power of influence in transforming women’s health
Over the past four years HRT prescriptions have doubled in the UK, the cause was turbo charged by the action of celebrities and influencers.
The doctor will text you now: Why healthcare providers cannot underestimate the importance of communicating change
Healthcare communication needs to switch from ‘transmit’ to ‘receive’, listening to what patients need and embracing the plethora of communication tools wholeheartedly.
Can tobacco companies really reinvent themselves as healthcare companies?
A surprising move by key player, Phillip Morris, has called attention to the start of a new era for the tobacco industry. But can tobacco companies reinvent themselves as healthcare...
Why you should feel optimistic about the future of healthcare
It has been a difficult year to remain hopeful for those working in the healthcare industry, but there are some reasons to remain optimistic.